Refine
Has Fulltext
- yes (29)
Is part of the Bibliography
- yes (29)
Year of publication
- 2016 (29) (remove)
Document Type
- Journal article (25)
- Doctoral Thesis (4)
Keywords
- chronic kidney disease (4)
- Diabetes mellitus (2)
- Fabry disease (2)
- cardiomyopathy (2)
- Addison's disease (1)
- Adrenocortial carcinomas (1)
- Alpha-Galactosidase (1)
- Anderson-Fabry Disease (1)
- Apoptosis (1)
- Autophagie (1)
- CKD (1)
- CML (1)
- Calcineurin-NFATsignaling (1)
- Cancer genetics (1)
- Cell lung canger (1)
- Chronic kidney disease (1)
- Cohort study (1)
- Contrast-enhanced CT (1)
- Cytoskeleton (1)
- D313Y genotype (1)
- DNA damage (1)
- DOTATOC (1)
- Disease prevalence (1)
- Diversity (1)
- Enzyme replacement therapy (1)
- Epidemiology (1)
- F-18-FDG PET/CT (1)
- Fabry cardiomyopathy (1)
- Fabry nephropathy (1)
- Fabry-associated pain (1)
- G protein coupled receptors (1)
- Galactosidase-A gene (1)
- Genome-wide association studies (1)
- Germany (1)
- Glycaemic control (1)
- Hemoglobin A1C (1)
- Hyponatriämie (1)
- Insulin therapy (1)
- Kidney function (1)
- Lag time (1)
- Lebensqualität (1)
- MR (1)
- Methodological quality (1)
- Morbus Fabry (1)
- Motorisches Gleichgewicht (1)
- Myeloma (1)
- Natural-history data (1)
- Nebenniere (1)
- Nebennierenerkrankung (1)
- Nebenniereninsuffizienz (1)
- Nebennierenkrise (1)
- Nebennierenrinde (1)
- Network (1)
- Oral antidiabetic drugs (1)
- Outcome survey (1)
- PET (1)
- Pain (1)
- Positron-emission-tomography (1)
- Racial differences (1)
- Rebreathing (1)
- Rückatmungsmethode (1)
- SCORE (1)
- SSTR (1)
- SUMO2 (1)
- Septal bulge (1)
- Spin echo (1)
- Test accuracy (1)
- Thymus (1)
- Typ-1-Diabetes (1)
- Zentrale Toleranz (1)
- activation (1)
- adenomas (1)
- adenoviruses (1)
- albumin excretion rate (1)
- allogeneic hematopoietic stem cell transplantation (1)
- antagonist (1)
- antidiabetic agents (1)
- biomarker (1)
- biomarkers (1)
- biopsy (1)
- blood pressure (1)
- blood pressure monitoring (1)
- bull’s eye plot (1)
- calcineurin signaling cascade (1)
- cancer risk (1)
- cardiac hypertrophy (1)
- cardiac pacing (1)
- cardiovascular disease (1)
- cardiovascular outcomes (1)
- chronic myeloid leukemia (1)
- chronische Hyponatriämie (1)
- clinical (1)
- converting enzyme-inhibition (1)
- cryptogenic stroke (1)
- cytoplasmic staining (1)
- diabetes (1)
- dietary sodium restriction (1)
- dogs (1)
- drug treatment (1)
- echocardiography (1)
- enzyme replacement therapy (1)
- fabry disease (1)
- fatal cardiovascular disease (1)
- glucocorticoid replacement therapy (1)
- glycemic control (1)
- health risk assessment (1)
- heart (1)
- heart disease (1)
- homeostasisIon channels (1)
- hyperexpression techniques (1)
- hypersensitivity (1)
- hypertension (1)
- hypertrophic cardiomyopathy (1)
- hyponatremia (1)
- immunofluorescence (1)
- infections (1)
- inherited metabolic disorders (1)
- insulin tolerance test (1)
- intensive glucose control (1)
- iron (1)
- late gadolinium enhancement (1)
- left ventricular hypertrophy (1)
- lysosomal storage disease (1)
- magnetic resonance spectroscopy (1)
- mutation (1)
- myocardial lipid content (1)
- myocardial fibrosis (1)
- nerve fibers (1)
- neuropathy (1)
- nuclear staining (1)
- overload (1)
- oxidative stress (1)
- pituitary adenomas (1)
- pituitary gland (1)
- protein expression (1)
- randomized trial (1)
- rare diseases (1)
- receptor (1)
- renal system (1)
- renoprotection (1)
- sarcoidosis (1)
- short Synacthen test (1)
- skin diseases (1)
- small interfering RNAs (1)
- somatostatin receptor (1)
- speckle tracking imaging (1)
- stage renal-disease (1)
- stem cell transplantation (1)
- thrombopoiesis (1)
- troponin T (1)
- tyrosine kinase inhibitors (1)
Institute
- Medizinische Klinik und Poliklinik I (29) (remove)
Sonstige beteiligte Institutionen
High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
(2016)
Background
High‐sensitivity troponin (hs‐TNT), a biomarker of myocardial damage, might be useful for assessing fibrosis in Fabry cardiomyopathy. We performed a prospective analysis of hs‐TNT as a biomarker for myocardial changes in Fabry patients and a retrospective longitudinal follow‐up study to assess longitudinal hs‐TNT changes relative to fibrosis and cardiomyopathy progression.
Methods and Results
For the prospective analysis, hs‐TNT from 75 consecutive patients with genetically confirmed Fabry disease was analyzed relative to typical Fabry‐associated echocardiographic findings and total myocardial fibrosis as measured by late gadolinium enhancement (LE) on magnetic resonance imaging. Longitudinal data (3.9±2.0 years), including hs‐TNT, LE, and echocardiographic findings from 58 Fabry patients, were retrospectively collected. Hs‐TNT level positively correlated with LE (linear correlation coefficient, 0.72; odds ratio, 32.81 [95% CI, 3.56–302.59]; P=0.002); patients with elevated baseline hs‐TNT (>14 ng/L) showed significantly increased LE (median: baseline, 1.9 [1.1–3.3] %; follow‐up, 3.2 [2.3–4.9] %; P<0.001) and slightly elevated hs‐TNT (baseline, 44.7 [30.1–65.3] ng/L; follow‐up, 49.1 [27.6–69.5] ng/L; P=0.116) during follow‐up. Left ventricular wall thickness and EF of patients with elevated hs‐TNT were decreased during follow‐up, indicating potential cardiomyopathy progression.
Conclusions
hs‐TNT is an accurate, easily accessible clinical blood biomarker for detecting replacement fibrosis in patients with Fabry disease and a qualified predictor of cardiomyopathy progression. Thus, hs‐TNT could be helpful for staging and follow‐up of Fabry patients.